![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 3.03% | 1.70 | 1.65 | 1.75 | 1.75 | 1.65 | 1.65 | 19,246,974 | 16:04:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -1.79 | 9.23M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/2/2021 09:39 | The chart is perfection !!!Next leg up from here Maybe RNS tommorow ..GDR like fridays | ![]() amaretto1 | |
04/2/2021 09:15 | Is seller now Finished ,is more of a move up going to be seen ,if they filling the large buy orders as seen yesterday ,as some of these buyers load up before next week part of rns Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously. "We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products." The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations. | ![]() bunz3 | |
04/2/2021 09:09 | Still don't see any news on sales figures come on DB !!! | ![]() pal44 | |
04/2/2021 08:57 | looking stronger again as more buyers loading up with shares again | ![]() bunz3 | |
04/2/2021 08:53 | Good summary se ball. | ![]() hazl | |
04/2/2021 08:51 | Don't know but l haven't sold any. Waiting for the golden ticket. | ![]() hazl | |
04/2/2021 08:50 | Some good sized buys as some load up before next week | ![]() bunz3 | |
04/2/2021 08:48 | Any chart experts on here?? | ![]() billthebank | |
04/2/2021 08:12 | some buyers picking up shares already this morning | ![]() bunz3 | |
04/2/2021 08:06 | Upcoming news flow for: #GDR Beckman validation ✅ Beckman partnership & orders Euro sales news Full FDA approval WHO approval India Approval Divoc deal PoC device launch and CE mark U.K. tender US DoD contract to be signed Launch of hearing loss kit Hep C kit Strong Buy this will rerate over next few months | ![]() seball | |
04/2/2021 07:45 | Sep800, it is 100 dollars a test not pounds. And that is the value to BC and not GDR (how much GDR get is unknown at the moment ) | hooded claw | |
04/2/2021 02:32 | Giving from the latest news, Figures of qualities and cost per test are being assess and these are in the region of.... Min 750 tests per 8 hour shift X 3 shift per 24 hours = 2250 test @ £100 min per test EQUALS Revenue per day £225K x 365 days per year giving revenue of £82.125M They want to increase this 2 fold shifts giving well over £164.25M per year. Expect further updates ref production figures. The current M/C will move to at least 3 fold plus from here. From latest News Genedrive PLC - Manchester-based molecular diagnostics firm - Enters into pact with Beckman Coulter Life Sciences for distribution of Genedrive's 96 SARS-CoV-2 Kit PCR test. Agreement allows Beckman to sell the tests in US and Europe. "We are very pleased to have the partnership of Beckman Coulter in accessing significant Covid testing opportunities throughout the United States and Europe, where the incidence of Covid continues to escalate and the need for high throughout testing solutions remains a priority," Genedrive Chief Executive Officer David Budd says. | ![]() sep800 | |
03/2/2021 22:24 | Lol arcade gambler | professor_santa | |
03/2/2021 19:11 | I think some of them are yesterday's | ![]() blackvulture | |
03/2/2021 18:56 | CMC showing 1 million plus trades after 6 | ![]() amaretto1 | |
03/2/2021 18:47 | Just hold ya water .. massive transactions tho .. 500,00050,00025,0001 | leetradey | |
03/2/2021 18:40 | It would make a lot of sense !! | ![]() amaretto1 | |
03/2/2021 18:36 | How large I can't see? | ![]() iantrader2 | |
03/2/2021 18:20 | Absolutely massive late trades gone through and I mean massive!!! | ![]() billthebank | |
03/2/2021 17:18 | Looking at the buys and sells something doesn't add up, anyone any idea as to what is going on. | ![]() jackdaw4243 | |
03/2/2021 14:13 | Funny how they made it nt at 92p to buy but didn't let anyone buy yet kept putting through the delayed sells and only sells then drop it. Looks like it was nt to buy as another big buyer is taking the stock and leaving some crumbs for anyone else to buy. Which is why they have left it hanging around this price until it is filled. | ![]() richardp19 | |
03/2/2021 14:09 | not easy for them to try and lower share price So many buyers who wanting to load up ,people who have read the rns | ![]() bunz3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions